Search
for
Sort by
Research 91–120 of 372
- The Impact of Covid-19 Pandemic on the Clinical Course of Pediatric Skin Disorders: A Cross-Sectional Study
- Manifestaciones dermatológicas por Covid-19 y su aporte en la comprensión de la enfermedad
- A patient with diffuse hair loss
- Comparación del efecto terapéutico entre el extracto etanólico del fruto de Physalis peruviana, Finasteride y Terazosine en la hiperplasia prostática benigna inducida en ratas
- Hypersensitivity Reactions to Anticoagulant Drugs
- Cutaneous signs in COVID ‐19 patients: A review
- Clinical manifestations of cutaneous lupus erythematosus
- Lupus erythematosus: systemic and cutaneous manifestations
- Dermatological adverse events with taxane chemotherapy
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Cutaneous lupus erythematosus
- Toxic Epidermal Necrolysis
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- The Spectrum of Skin Disease Among Indian Children
- Graft-versus-host disease
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Acneiform Dermatoses
- Update on the dermatologic use of systemic glucocorticosteroids
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- Lupus panniculitis clinically simulating alopecia areata
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Psychodermatology
- Interventions for morphea
- Nutrition and the deleterious side effects of nutritional supplements
- Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost
- CUTANEOUS SIDE-EFFECTS OF BETA-ADRENERGIC BLOCKERS
- Cutaneous manifestations of metabolic diseases: uncommon presentations
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy